[go: up one dir, main page]

AU2327192A - Indoles - Google Patents

Indoles

Info

Publication number
AU2327192A
AU2327192A AU23271/92A AU2327192A AU2327192A AU 2327192 A AU2327192 A AU 2327192A AU 23271/92 A AU23271/92 A AU 23271/92A AU 2327192 A AU2327192 A AU 2327192A AU 2327192 A AU2327192 A AU 2327192A
Authority
AU
Australia
Prior art keywords
indoles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU23271/92A
Other languages
English (en)
Inventor
Julian Blagg
Kelvin Cooper
Peter Lionel Spargo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Publication of AU2327192A publication Critical patent/AU2327192A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12Radicals substituted by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
AU23271/92A 1991-07-24 1992-07-20 Indoles Abandoned AU2327192A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9115951 1991-07-24
GB919115951A GB9115951D0 (en) 1991-07-24 1991-07-24 Indoles

Publications (1)

Publication Number Publication Date
AU2327192A true AU2327192A (en) 1993-02-23

Family

ID=10698873

Family Applications (2)

Application Number Title Priority Date Filing Date
AU23271/92A Abandoned AU2327192A (en) 1991-07-24 1992-07-20 Indoles
AU23270/92A Expired - Fee Related AU655662B2 (en) 1991-07-24 1992-07-20 pndoles

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU23270/92A Expired - Fee Related AU655662B2 (en) 1991-07-24 1992-07-20 pndoles

Country Status (20)

Country Link
EP (2) EP0598750A1 (no)
JP (2) JPH06511483A (no)
CN (2) CN1068816A (no)
AU (2) AU2327192A (no)
BR (1) BR9206306A (no)
CA (2) CA2112689A1 (no)
CZ (1) CZ13694A3 (no)
FI (2) FI940310A (no)
GB (1) GB9115951D0 (no)
HU (1) HU9400199D0 (no)
IE (2) IE922387A1 (no)
IL (2) IL102544A0 (no)
MX (1) MX9204342A (no)
NO (1) NO940237L (no)
NZ (1) NZ243687A (no)
PT (2) PT100718A (no)
SK (1) SK8494A3 (no)
TW (1) TW223060B (no)
WO (2) WO1993002050A1 (no)
ZA (2) ZA925546B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9204024D0 (en) * 1992-02-25 1992-04-08 Fujisawa Pharmaceutical Co Indole derivatives
GB9302577D0 (en) * 1993-02-10 1993-03-24 Fujisawa Pharmaceutical Co Indole derivatives
US5530019A (en) * 1993-04-05 1996-06-25 Fujisawa Pharmaceutical Co., Ltd. Indole derivatives useful as testosterone 5α-reductase inhibitors
GB9310092D0 (en) * 1993-05-17 1993-06-30 Fujisawa Pharmaceutical Co Indole derivatives
GB9317096D0 (en) * 1993-08-17 1993-09-29 Pfizer Ltd Indoles
KR100349634B1 (ko) * 1994-03-30 2003-01-08 제리아 신야쿠 고교 가부시키 가이샤 인돌유도체및이를함유하는제제
GB9409583D0 (en) * 1994-05-13 1994-07-06 Pfizer Ltd Indoles
US5543417A (en) * 1994-10-21 1996-08-06 Merck & Co., Inc. Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
PL207885B1 (pl) 1997-05-14 2011-02-28 Atherogenics Inc Pochodna probukolu i kompozycja zawierająca pochodną probukolu
US6670398B2 (en) 1997-05-14 2003-12-30 Atherogenics, Inc. Compounds and methods for treating transplant rejection
US7417063B2 (en) 2004-04-13 2008-08-26 Bristol-Myers Squibb Company Bicyclic heterocycles useful as serine protease inhibitors
FR2893615B1 (fr) * 2005-11-18 2008-03-07 Sanofi Aventis Sa Derives de 3-acylindole, leur preparation et leur application en therapeutique
PE20090159A1 (es) 2007-03-08 2009-02-21 Plexxikon Inc COMPUESTOS DERIVADOS DE ACIDO INDOL-PROPIONICO COMO MODULADORES PPARs
EP2139320A4 (en) 2007-03-26 2010-09-08 Salutria Pharmaceuticals Llc METHODS AND COMPOSITIONS OF PROBUCOL DERIVATIVES FOR THE TREATMENT OF DIABETES
US10703969B2 (en) * 2016-09-27 2020-07-07 Kaohsiung Medical University Detection method for quaternary ammonium compound having γ-carboxyl group

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9011335D0 (en) * 1990-05-21 1990-07-11 Fujisawa Pharmaceutical Co Indolebutyric acid derivatives and process for preparation thereof
WO1993005020A1 (en) * 1991-09-06 1993-03-18 Merck & Co., Inc. Indoles as inhibitors of hiv reverse transcriptase

Also Published As

Publication number Publication date
FI940310A0 (fi) 1994-01-21
CZ13694A3 (en) 1994-07-13
JPH06509336A (ja) 1994-10-20
PT100718A (pt) 1993-08-31
AU655662B2 (en) 1995-01-05
FI940311A (fi) 1994-01-21
FI940311A0 (fi) 1994-01-21
CA2112689A1 (en) 1993-02-04
ZA925546B (en) 1994-01-24
CN1068817A (zh) 1993-02-10
NO940237D0 (no) 1994-01-24
IL102545A0 (en) 1993-01-14
FI940310A (fi) 1994-01-21
WO1993002051A1 (en) 1993-02-04
EP0598750A1 (en) 1994-06-01
EP0598754A1 (en) 1994-06-01
CA2112678A1 (en) 1993-02-04
MX9204342A (es) 1994-03-31
IE922386A1 (en) 1993-01-27
NZ243687A (en) 1994-12-22
NO940237L (no) 1994-01-24
IE922387A1 (en) 1993-01-27
WO1993002050A1 (en) 1993-02-04
BR9206306A (pt) 1994-11-08
PT100717A (pt) 1993-08-31
SK8494A3 (en) 1994-11-09
AU2327092A (en) 1993-02-23
HU9400199D0 (en) 1994-05-30
ZA925547B (en) 1994-01-24
JPH06511483A (ja) 1994-12-22
CN1068816A (zh) 1993-02-10
TW223060B (no) 1994-05-01
GB9115951D0 (en) 1991-09-11
IL102544A0 (en) 1993-01-14

Similar Documents

Publication Publication Date Title
AU6018194A (en) Easy intubator
AU3692393A (en) Indole derivatives
AU655472B2 (en) Imidazodiazepines
AU3349893A (en) Indole derivatives
AU653847B2 (en) Benzodioxanderivate
AP9200417A0 (en) 3-piperidinylmethylcarboxylate substituted indoles
AU1604492A (en) Indole derivatives
AU654362B2 (en) Pyrrolopyrazines
AU1782292A (en) Gridbeam
AU2135292A (en) Cyanophenylpyrroles
AU2327192A (en) Indoles
AU2636292A (en) Anti-alpha6-integrin-antibodies
AU1556892A (en) 2-substituted-2-imidazolines
AU1080292A (en) Ige-receptor-antibodies
AU1766292A (en) Ibuprofen-decongestant combinations
AU1033992A (en) 3-quinuclidine derivatives
AU2586192A (en) Imaginograph
AU1752492A (en) Diamino-alpha-alkylstilbenes
AU1732692A (en) Substituted imidazolinylpyrimidines
AU3018192A (en) Sulfonimidamides
AU647640B2 (en) Quinolin-2-yl-methoxybenzylhydroxyureas
AU2979992A (en) Quinolylmethoxyphenyl-acetamides
AU1669792A (en) Azabicycloheptanone
AU1624092A (en) Mopheads
AU1588892A (en) Watch-strap